While our initial experiments did show promising results, future studies are still needed to determine exactly what cells are affected by the introduction of survivin and whether it is possible to safely modify healthy tissue without conferring radiation resistance to any residual tumor cells. This evidence concerns the gene BIRC5 and neoplasm.